Kevin S. Sr. Boyle

Insider Reports History

Entity
Individual
Location
C/O Ziopharm Oncology, Inc., One First Avenue, Parris Bldg 34, Boston, MA
Signature
/s/ Melinda Lackey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin S. Sr. Boyle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alaunos Therapeutics, Inc. Chief Executive Officer, Director Common Stock 798K $112K $0.14 Sep 1, 2023 Direct

Insider Reports Filed by Kevin S. Sr. Boyle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRT Alaunos Therapeutics, Inc. Sep 1, 2023 1 -$9.54K 4 Sep 5, 2023 Chief Executive Officer, Director
TCRT Alaunos Therapeutics, Inc. Mar 15, 2023 1 $0 4 Mar 17, 2023 Chief Executive Officer, Director
TCRT Alaunos Therapeutics, Inc. Aug 30, 2022 1 -$45.2K 4 Sep 1, 2022 Chief Executive Officer, Director
TCRT Alaunos Therapeutics, Inc. Mar 30, 2022 1 $0 4 Apr 1, 2022 Chief Executive Officer, Director
TCRT ZIOPHARM ONCOLOGY INC Nov 16, 2021 2 $14K 4 Nov 17, 2021 Chief Executive Officer, Director
TCRT ZIOPHARM ONCOLOGY INC Aug 30, 2021 2 $0 4 Aug 31, 2021 Chief Executive Officer, Director
TCRT ZIOPHARM ONCOLOGY INC Aug 30, 2021 0 $0 3 Aug 31, 2021 Chief Executive Officer, Director